Cargando…
Dendritic Cell-Derived Exosomes may be a Tool for Cancer Immunotherapy by Converting Tumor Cells into Immunogenic Targets
Dendritic cells (DCs) have been attracting attention in cancer immunotherapy because of their role in inducing and modulating effective immune responses. Besides the direct contact with other cell types and the secretion of cytokines, it is becoming clear that nanovesicles, such as exosomes (Exo), s...
Autores principales: | Romagnoli, Graziela Gorete, Zelante, Bruna Barbosa, Toniolo, Patrícia Argenta, Migliori, Isabella Katz, Barbuto, José Alexandre M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4298225/ https://www.ncbi.nlm.nih.gov/pubmed/25646096 http://dx.doi.org/10.3389/fimmu.2014.00692 |
Ejemplares similares
-
What Are the Molecules Involved in Regulatory T-Cells Induction by Dendritic Cells in Cancer?
por: Ramos, Rodrigo Nalio, et al.
Publicado: (2013) -
Dendritic Cell-Derived Exosomes in Cancer Immunotherapy
por: Luo, Shumin, et al.
Publicado: (2023) -
Propolis anti-inflammatory effects on MAGE-1 and retinoic
acid-treated dendritic cells and on Th1 and T regulatory cells
por: Santiago, Karina Basso, et al.
Publicado: (2023) -
Dendritic cells loaded with tumor derived exosomes for cancer immunotherapy
por: Liu, Hongyu, et al.
Publicado: (2017) -
Human Dendritic Cells: Their Heterogeneity and Clinical Application Potential in Cancer Immunotherapy
por: Patente, Thiago A., et al.
Publicado: (2019)